Page URL:

BioNews Comment articles written by James Lawford Davies:

Page 1 of 1
An embarrassment of riches
20 February 2012 - by James Lawford Davies
It is evident that the Human Fertilisation and Embryology Authority (HFEA) has succeeded in reducing its costs and operating with greater financial efficiency. This is in part reflected in the remarkable £3.4 million of surplus funds held by the HFEA which was discussed at the recent Authority meeting in January and subsequently reported in the media... [Read More]
HFEA must address its 'misconceived interventions'
21 February 2011 - by James Lawford Davies
On the morning of 15 January 2007, I attended a meeting about hybrid embryo research in the UK Parliament. Halfway through, I received a message from a journalist that fertility regulator the Human Fertilisation and Embryology Authority (HFEA) had announced there would be a press conference that lunchtime about a London IVF clinic, the Assisted Reproduction and Gynaecology Centre (ARGC). As I left the meeting, I was called and asked to go to the ARGC urgently... [Read More]
Regulating IVF and embryo research: Balancing clarity with flexibility
19 July 2007 - by James Lawford Davies
I will miss the UK's Human Fertilisation and Embryology (HFE) 1990 Act when it is gone. I am no great supporter of our regulatory model and the 1990 Act is flawed and idiosyncratic. However, if you are going to regulate IVF and embryo research, ours is a reasonably solid regulatory... [Read More]
The effects - or not - of the EU Tissue Directive
10 April 2006 - by James Lawford Davies
After four years of speculation, debate and revision, the EU Tissues and Cells Directive has finally (if quietly) come into force. Sort of. The Directive, binding on all EU Member States, is part of a programme of legislation intended to introduce quality assurance for European consumers. As the title of... [Read More]
Made in the UK
7 February 2006 - by James Lawford Davies
The Human Genetics Commission (HGC)'s recent report 'Making Babies: Reproductive decisions and genetic technologies' is the welcome result of two years' consultation and debate. For the most part, the report offers clear and constructive conclusions and recommendations for the future of assisted reproduction and preimplantation genetic diagnosis (PGD), amongst... [Read More]